ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.

February 13, 2004

Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.

January 26, 2001

Women’s Health Initiative: Cutting Fat Has Small Effect On Breast Cancer Risk

February 24, 2006

Consensus Growing On Prevention Strategies: Higginson

August 14, 1981

Communication Is Key To Clinical Trial Enrollment

June 30, 2006

Late Effects In Breast Cancer Treatment Found In Study

January 25, 2002